The optimal position of IARCs in the research-development path is still contested.
Transaction costs economics can be applied to assess their comparative advantage.
Comparative advantage depends on capacity of NARES to handle governance challenges.
In the short run, assessment of national capacities should guide task allocation.
In the long run, it is cost-effective for donors to invest in capacity building.